相关实验视频
Updated: May 12, 2025

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
10.3K
在帕金森病的实验性大鼠模型中,阿德罗具有神经保护作用
Ayse Ozkan1,2, Hande Parlak1,3, Osman Sinen1
1Department of Physiology, Akdeniz University, Faculty of Medicine, Antalya, Turkey.
Iranian journal of basic medical sciences
|May 9, 2025
概括
在帕金森病患者中,阿德罗治疗改善了运动功能,并保护了多巴胺能神经元.
科学领域:
- 神经科学是一个神经科学.
- 神经退行性疾病 神经退行性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特征是多巴胺能神经元的损失.
- 了解神经保护背后的机制对于开发有效的治疗方法至关重要.
研究的目的:
- 在帕金森病的小鼠模型中研究阿德罗宾的保护作用.
- 阐明阿德罗作用的潜在分子机制.
主要方法:
- 一种6-氧多巴胺化 (6-OHDA) 诱导的帕金森病模型在Wistar大鼠中.
- 对氨酸氧酶 (TH),G蛋白结合受体19 (GPR19) 和血管内皮生长因子受体2 (VEGFR2) 的运动性能,免疫组织化学评估.
- 测量多巴胺水平和西斑分析GSK3β信号通路.
主要成果:
- 阿德罗治疗显著改善了PD大鼠的运动性能.
- 阿德罗的使用保存了尼格拉尔多巴胺基神经元,并增加了VEGFR2表达.
- 在adropin治疗后,黑色物质 (SN) 中的多巴胺水平升高.
结论:
- 在PD模型中,阿德罗对尼格拉尔多巴胺基神经元表现出保护作用.
- 阿德罗宾的保护机制涉及VEGFR2信号通路.
更多相关视频
08:06Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
31.5K
08:33Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Published on: February 28, 2016
13.2K
相关概念视频
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Parkinson's Disease: Overview
319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K